Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01280097 · ClinicalTrials.gov registry record
Study of Sleep and Delirium in the Intensive Care Unit (ICU)
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 57
- Enrollment target
NCT01280097: Completed study, sponsored by University of California, San Francisco.
NCT01280097 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 57 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01280097 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 57 participants
- Enrollment target
Study Summary
The investigators will perform a prospective, cohort study of 100 older intensive care unit (ICU) patients, to investigate the association between sleep disruption and ICU delirium.
Primary Outcome
ICU delirium will be measured using the CAM-ICU. This measurement will be done twice daily.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2010-12 |
| Est. Completion | 2012-11 |
What the finished NCT01280097 record still lists
NCT01280097 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 57 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01280097 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01280097 about?
NCT01280097 is a clinical study titled "Study of Sleep and Delirium in the Intensive Care Unit (ICU)". The investigators will perform a prospective, cohort study of 100 older intensive care unit (ICU) patients, to investigate the association between sleep disruption and ICU delirium.
What is the current status of trial NCT01280097?
This trial is currently completed. The enrollment target is 57 participants. The study started on 2010-12. Estimated completion is 2012-11.
Who is sponsoring clinical trial NCT01280097?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03521830 · 57 participants · Phase 2
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
- NCT03587701 · 57 participants · Phase 2
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
- NCT04104126 · 57 participants · NA
Blood Flow Restriction Therapy in Achilles Injury
- NCT04703842 · 57 participants · Phase 1
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia